EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024


Werte in diesem Artikel
Aktien

171.50 EUR -5.55 EUR -3.13 %

Disclosure of Share Capital and Voting Rights Outstanding
as of October 31, 2024

Werbung

(Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des Marchés Financiers)

Paris, France (November 8, 2024 - 6:00 pm) – As of October 31, 2024, shares and voting rights outstanding of EssilorLuxottica, the global leader in the design, manufacture and distribution of ophthalmic lenses, frames and sunglasses, breaks down as indicated below.

 October 31, 2024
Shares outstanding457,322,5071
Number of real voting rights (excluding treasury shares)456,762,601
Theoretical number of voting rights (including treasury shares)457,322,507

It is to be noted that voting rights are capped at 31%, applicable to any shareholder, in accordance with a formula contained in article 23 of EssilorLuxottica’s by-laws2.

Werbung

For further information, please consult the Prospectus which received Visa No. 18-460 from the AMF on September 28, 2018 and its Securities Note Supplement which received Visa No. 18-494 from the AMF on October 23, 2018, available on the website www.essilorluxottica.com.

1Including 4,216 shares delivered but not yet registered as of October 31, 2024.
2EssilorLuxottica’s by-laws are available on the Company’s website under the section Governance / Publications.

Attachment


Aktuelle EssilorLuxottica Aktie News

Werbung

EssilorLuxottica Analysen

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für EssilorLuxottica nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
DatumRatingAnalyst
02.07.26 EssilorLuxottica Buy UBS AG
02.07.26 EssilorLuxottica Outperform RBC Capital Markets
30.06.26 EssilorLuxottica Overweight JP Morgan Chase & Co.
29.06.26 EssilorLuxottica Market-Perform Bernstein Research
29.06.26 EssilorLuxottica Buy Goldman Sachs Group Inc.